GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
GLOBUS MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$75.65−1.06 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $10.39B
- P/E (TTM)
- 19.3
- Dividend yield
- –
Globus Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Globus Medical | Industry median |
|---|---|---|
| Market Cap | $10.16B | $230.55M |
| Enterprise Value | $9.56B | $202.97M |
| PE Ratio | 19.35 | 31.60 |
| PS Ratio | 3.23 | 3.10 |
| PB Ratio | 2.13 | 3.04 |
| P/TBV Ratio | 3.85 | 4.43 |
| P/FCF Ratio | 13.44 | 27.30 |
| P/OCF Ratio | 11.16 | 22.47 |
Enterprise value
| Measure | Globus Medical | Industry median |
|---|---|---|
| EV / Sales | 3.04 | 2.91 |
| EV / EBITDA | 10.40 | 19.74 |
| EV / EBIT | 14.95 | 24.80 |
| EV / FCF | 12.65 | 27.89 |
Income (trailing twelve months)
| Measure | Globus Medical | Industry median |
|---|---|---|
| Revenue | $3.14B | $102.39M |
| Gross Profit | $2.16B | $60.36M |
| Operating Income | $639.52M | -$4.31M |
| Pretax Income | $660.12M | -$2.37M |
| Net Income | $535.43M | -$6.57M |
| EBITDA | $919.44M | -$1.98M |
| EPS (Diluted) | $3.91 | -$0.08 |
Margins
| Measure | Globus Medical | Industry median |
|---|---|---|
| Gross Margin | 68.5% | 55.2% |
| Operating Margin | 20.3% | -6.04% |
| Pretax Margin | 21.0% | -4.11% |
| Profit Margin | 17.0% | -10.5% |
| EBITDA Margin | 29.2% | -2.67% |
| FCF Margin | 24.0% | 0.02% |
Returns
| Measure | Globus Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.8% | -18.2% |
| Return on Assets (ROA) | 10.2% | -13.3% |
| Return on Invested Capital (ROIC) | 12.6% | -3.69% |
| Return on Capital Employed (ROCE) | 12.8% | -9.07% |
Growth
| Measure | Globus Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 19.7% | 8.85% |
| Net Income Growth (YoY) | 50.1% | 10.5% |
| EPS Growth (YoY) | 50.4% | 10.6% |
| FCF Growth (YoY) | 43.3% | 9.68% |
| Revenue Growth (3Y CAGR) | 42.2% | 7.08% |
| Revenue Growth (5Y CAGR) | 30.1% | 11.8% |
| EPS Growth (3Y CAGR) | 28.4% | 3.11% |
| EPS Growth (5Y CAGR) | 31.2% | 7.64% |
Balance sheet
| Measure | Globus Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $595.14M | $36.66M |
| Net Cash (Debt) | $595.14M | $3.92M |
| Net Cash Per Share | $4.43 | $0.28 |
| Equity (Book Value) | $4.77B | $55.33M |
| Book Value Per Share | $35.52 | $2.87 |
| Tangible Book Value | $2.64B | $10.79M |
| Working Capital | $1.74B | $56.72M |
Financial position
| Measure | Globus Medical | Industry median |
|---|---|---|
| Current Ratio | 4.62 | 2.48 |
| Quick Ratio | 2.69 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Globus Medical | Industry median |
|---|---|---|
| Operating Cash Flow | $910.39M | -$566.22K |
| Capital Expenditures | -$154.80M | -$3.69M |
| Free Cash Flow | $755.59M | -$696.00K |
| FCF Per Share | $5.63 | -$0.02 |
Efficiency
| Measure | Globus Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.60 | 0.58 |
| Inventory Turnover | 1.25 | 2.21 |
| Revenue Per Employee | $524.16K | $322.92K |
| Profits Per Employee | $89.24K | -$51.88K |
| Employee Count | 6,000 | 185 |
Dividends and yields
| Measure | Globus Medical | Industry median |
|---|---|---|
| Earnings Yield | 5.27% | -6.88% |
| FCF Yield | 7.44% | -0.45% |
| Buyback Yield | 2.18% | 0.78% |
| Shareholder Yield | 2.18% | 0.80% |
Shares
| Measure | Globus Medical | Industry median |
|---|---|---|
| Shares Outstanding | 134,262,000 | 44,302,700 |
| Shares Change (YoY) | -1.18% | 3.36% |
| Float | 110,376,000 | 37,462,700 |
| Shares Held by Insiders | 17.8% | 10.5% |
| Shares Held by Institutions | 88.9% | 63.5% |
Taxes
| Measure | Globus Medical | Industry median |
|---|---|---|
| Income Tax | $124.69M | $1.52M |
| Effective Tax Rate | 18.9% | 18.5% |
Scores
| Measure | Globus Medical | Industry median |
|---|---|---|
| Graham Number | $55.90 | $35.97 |
| Graham Upside | -26.1% | -57.0% |
| Altman Z-Score | 10.19 | 1.95 |
| Piotroski F-Score | 9 | 5 |
| Beneish M-Score | -2.41 | -2.64 |
Calculated by StockData from Globus Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.